Park HJ

Washington University in St. Louis

1
Publications in this database

PubMed name variants: Park HJ. Uses the same surname-and-first-initial grouping as the researcher table; matches are not verified identities.

5
Career-wide h-index · OpenAlex
(275 citations, 7 total works)

Career-wide Research Topics · OpenAlex

Topic counts cover the OpenAlex author’s full publication record, across all conditions.

Complement system in diseases (2)Job Satisfaction and Organizational Behavior (1)Malaria Research and Control (1)Rheumatoid Arthritis Research and Therapies (1)Systemic Lupus Erythematosus Research (1)

Erythromelalgia Publications

Neoplastic and paraneoplastic vasculitis, vasculopathy, and hypercoagulability.

Park HJ, Ranganathan P
Rheumatic diseases clinics of North America •

It is essential to be aware of both neoplastic and paraneoplastic vasculitides, vasculopathy, and hypercoagulability, considering the importance of an accurate diagnosis and timely treatment of the underlying malignancy. Characteristics such as the type of vasculitis, age, gender, atypical presentation, and lack of response to common therapies should prompt investigation for an occult malignancy, whereas vasculitis such as GPA require due malignancy vigilance given a significantly increased risk of malignancy at the time of diagnosis and in the following years. Vasculopathies are rarer than vasculitides, but are associated with specific malignancies and, in the context of such malignancies, should be kept in mind. Hypercoagulability is a well-documented neoplastic phenomenon with an increased risk of thrombosis in the setting of positive aPLs. Most neoplastic and paraneoplastic vascular syndromes require no specific treatment outside of treatment of the underlying malignancy. The two key exceptions are PACNS, because of its poor prognosis, and erythromelalgia, in which aspirin is an effective agent.